查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1541547

光化性角化症治療市場報告（按類型（處方藥、非處方藥）、藥物類型（氟尿嘧啶、咪喹莫特、雙氯芬酸等）、配銷通路（醫院藥房、藥房和零售藥房、網路商店）和地區2024- 2032年

Actinic Keratosis Treatment Market Report by Type (Prescription, OTC), Drug Type (Fluorouracil, Imiquimod, Diclofenac, and Others), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Stores), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球光化性角化病治療市場規模達64億美元。

光化性角化病，又稱日光性角化病，是指身體暴露在陽光下的部位出現的皮膚病。它會導致手、手臂、嘴唇、頭皮和其他身體部位出現粗糙的鱗狀斑塊，這些斑塊可能進一步發展為稱為鱗狀細胞癌的皮膚癌。一些常用的去除光化性角化症的治療方法包括冷凍療法、刮除術、雷射療法和光動力療法。目前，醫療基礎設施的大幅擴張和對癌症預防策略的需求不斷增加，正在對全球光化性角化病治療的需求產生積極影響。

光化性角化症治療市場趨勢：

由於臭氧層消耗和過度陽光照射，光化性角化症的盛行率不斷增加，這是推動市場成長的關鍵因素之一。此外，癌症發生率的上升，加上對微創（MI）手術的需求不斷增加，正在加強市場的成長。此外，領先的製造商正在推出乳膏和凝膠形式的治療光化性角化病的藥物，這推動了市場的成長。除此之外，許多公共和私人團體正在重點開展活動，以提高人們對全球光化性角化病可用治療方法的認知。再加上對研發（R＆D）活動的​​大量投資，以開發具有更高療效、方便劑量和降低成本的新型療法，正在創造有利的市場前景。降低疤痕風險的局部治療的推出也推動了市場的發展。這種治療方法也用於治療皮膚上大面積可見和不可見的病變。除此之外，有利的報銷政策預計將推動市場成長。

本報告回答的關鍵問題：

  • 迄今為止，全球光化性角化症治療市場表現如何，未來幾年將如何表現？
  • COVID-19 對全球光化性角化症治療市場有何影響？
  • 主要區域市場有哪些？
  • 依類型分類市場是怎麼樣的？
  • 根據藥物類型分類的市場是怎麼樣的？
  • 基於配銷通路的市場區隔是什麼？
  • 產業價值鏈的各個階段是什麼？
  • 該行業的關鍵促進因素和挑戰是什麼？
  • 全球光化性角化症治療市場的結構如何？
  • 產業競爭程度如何？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球光化性角化症治療市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按類型

  • 處方
    • 市場趨勢
    • 市場預測
  • 場外交易
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：按藥物類型

  • 氟尿嘧啶
    • 市場趨勢
    • 市場預測
  • 咪喹莫特
    • 市場趨勢
    • 市場預測
  • 雙氯芬酸
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：按配銷通路

  • 醫院藥房
    • 市場趨勢
    • 市場預測
  • 藥局和零售藥局
    • 市場趨勢
    • 市場預測
  • 網路商店
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • 3M Company
    • Almirall SA
    • Bausch Health Companies Inc.
    • Biofrontera Inc.
    • BioLineRx Ltd.
    • Cipher Pharmaceuticals Inc
    • Galderma SA
    • Hill Dermaceuticals Inc.
    • LEO Pharma A/S
    • Sun Pharmaceutical Industries Ltd.
Product Code: SR112024A4085

The global actinic keratosis treatment market size reached US$ 6.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.7 Billion by 2032, exhibiting a growth rate (CAGR) of 4.5% during 2024-2032.

Actinic keratosis, also known as solar keratosis, refers to a skin condition that develops on the sun-exposed areas of the body. It causes rough, scaly patches to appear on the hands, arms, lips, scalp, and other body parts that can further develop into a skin cancer called squamous cell carcinoma. Some of the commonly used treatments to remove actinic keratosis include cryotherapy, curettage, laser therapy, and photodynamic therapy. At present, the considerably expanding healthcare infrastructure and increasing need for preventive strategies for cancer are positively influencing the demand for actinic keratosis treatment worldwide.

Actinic Keratosis Treatment Market Trends:

The increasing prevalence of actinic keratosis due to ozone layer depletion and excessive sun exposure represents one of the key factors fueling the growth of the market. Additionally, the rising incidences of cancer, coupled with the escalating demand for minimally invasive (MI) procedures, is strengthening the market growth. Furthermore, leading manufacturers are introducing medications for the treatment of actinic keratosis in the form of cream and gel, which is impelling the market growth. Apart from this, numerous public and private groups are focusing on conducting campaigns to generate awareness about available treatments for actinic keratosis across the globe. This, along with significant investments in the research and development (R&D) activities to develop novel therapies with improved efficacy, convenient dosage, and reduced costs, is creating a favorable market outlook. The market is also driven by the introduction of topical treatment that reduces the risk of scarring. This treatment is also used for treating a wide area of visible and invisible lesions on the skin. Besides this, favorable reimbursement policies are anticipated to fuel the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global actinic keratosis treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, drug type, and distribution channel.

Breakup by Type:

Prescription

OTC

Breakup by Drug Type:

Fluorouracil

Imiquimod

Diclofenac

Others

Breakup by Distribution Channel:

Hospital Pharmacies

Drug Stores and Retail Pharmacies

Online Stores

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Almirall SA, Bausch Health Companies Inc., Biofrontera Inc., BioLineRx Ltd., Cipher Pharmaceuticals Inc, Galderma SA, Hill Dermaceuticals Inc., LEO Pharma A/S and Sun Pharmaceutical Industries Ltd.

Key Questions Answered in This Report:

  • How has the global actinic keratosis treatment market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global actinic keratosis treatment market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the drug type?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global actinic keratosis treatment market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Actinic Keratosis Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Prescription
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 OTC
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Drug Type

  • 7.1 Fluorouracil
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Imiquimod
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Diclofenac
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Drug Stores and Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 3M Company
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Almirall SA
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Bausch Health Companies Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Biofrontera Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 BioLineRx Ltd.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 Cipher Pharmaceuticals Inc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Galderma SA
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Hill Dermaceuticals Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 LEO Pharma A/S
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Sun Pharmaceutical Industries Ltd.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Actinic Keratosis Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Actinic Keratosis Treatment Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Actinic Keratosis Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Actinic Keratosis Treatment Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Actinic Keratosis Treatment Market: Breakup by Drug Type (in %), 2023
  • Figure 6: Global: Actinic Keratosis Treatment Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Actinic Keratosis Treatment Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Actinic Keratosis Treatment (Prescription) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Actinic Keratosis Treatment (Prescription) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Actinic Keratosis Treatment (OTC) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Actinic Keratosis Treatment (OTC) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Actinic Keratosis Treatment (Fluorouracil) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Actinic Keratosis Treatment (Fluorouracil) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Actinic Keratosis Treatment (Imiquimod) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Actinic Keratosis Treatment (Imiquimod) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Actinic Keratosis Treatment (Diclofenac) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Actinic Keratosis Treatment (Diclofenac) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Actinic Keratosis Treatment (Other Drug Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Actinic Keratosis Treatment (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Actinic Keratosis Treatment (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Actinic Keratosis Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Actinic Keratosis Treatment (Drug Stores and Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Actinic Keratosis Treatment (Drug Stores and Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Actinic Keratosis Treatment (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Actinic Keratosis Treatment (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: North America: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: North America: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: United States: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: United States: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Canada: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Canada: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Asia-Pacific: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Asia-Pacific: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: China: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: China: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Japan: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Japan: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: India: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: India: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: South Korea: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: South Korea: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Australia: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Australia: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Indonesia: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Indonesia: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Others: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Others: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Europe: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Europe: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Germany: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Germany: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: France: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: France: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: United Kingdom: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: United Kingdom: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Italy: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Italy: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Spain: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Spain: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Russia: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Russia: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Others: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Others: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Latin America: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Latin America: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Brazil: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Brazil: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Mexico: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Mexico: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Middle East and Africa: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Middle East and Africa: Actinic Keratosis Treatment Market: Breakup by Country (in %), 2023
  • Figure 74: Middle East and Africa: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Global: Actinic Keratosis Treatment Industry: SWOT Analysis
  • Figure 76: Global: Actinic Keratosis Treatment Industry: Value Chain Analysis
  • Figure 77: Global: Actinic Keratosis Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Actinic Keratosis Treatment Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Actinic Keratosis Treatment Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Actinic Keratosis Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
  • Table 4: Global: Actinic Keratosis Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Actinic Keratosis Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Actinic Keratosis Treatment Market: Competitive Structure
  • Table 7: Global: Actinic Keratosis Treatment Market: Key Players